Contents

Search

gp100:209-217(210 M) peptide vaccine

Indications: - investigational use in conjunction with IL-2 for treatment of metastatic melanoma

General

vaccine antineoplastic agent (chemotherapeutic agent)

References

  1. Schwartzentruber DJ et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med 2011 Jun 2; 364:2119 PMID: 21631324